Ultra-performance liquid chromatography/tandem mass spectrometry method for the determination of lercanidipine in human plasma

Rapid Communications in Mass Spectrometry

Volumn 20, Issue 19, 2006, Pages 2939-2946

  Kalovidouris, Madgalene ^a,b   Michalea, Stavroula ^b   Robola, Nikoleta ^b   Koutsopoulou, Maria ^b   Panderi, Irene ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b Independent Research and Laboratory Solutions   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG PRODUCTS; ELECTROSPRAY IONIZATION; HIGH PRESSURE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PARTICLE SIZE; PARTICLE SIZE ANALYSIS; PLASMA (HUMAN); POSITIVE IONS; SOLVENT EXTRACTION;

ELECTROSPRAY IONIZATION TANDEM MASS SPECTROMETRY; ESI-MS-MS; HUMAN PLASMAS; INTERNAL STANDARDS; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY; NICARDIPINE; POSITIVE ELECTROSPRAY IONIZATION; SIMPLE++; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

QUALITY CONTROL;

EID: 33749515425     PISSN: 09514198     EISSN: 10970231     Source Type: Journal    
DOI: 10.1002/rcm.2693     Document Type: Article

References (23)

1. Venkata C, Ram S. Am. J. Cardiol. 2002; 89: 214.
2. McClellan KJ, Jarvis B. Drugs 2000; 60: 1123.
3. De Giorgio L, Orlandini F, Malasoma P, Zappa A. Curr. Therapeut. Res. 1999; 60: 511.
4. Omboni S, Zanchetti A. J. Hypertension 1998; 16: 1831.
5. Bang LM, Chapman TM, Goa KL. Drugs 2003; 63: 2449.
6. Barchielli M, Dolfini E, Farina P. J. Cardiovasc. Pharmacol. 1997; 29: S2.
7. Salem II, Idrees J, Al Tamimi JI, Farina P. J. Chromatogr. B 2004; 803: 201.
8. Jabor VA, Coelho EB, Ifa DR, Bonato PS, dos Santos NA, Lanchote VL. J. Chromatogr. B 2003; 796: 429.
9. Jabor VA, Coelho EB, Ifa DR, Bonato PS, dos Santos NA, Lanchote VL. J. Chromatogr. B 2004; 813: 343.
10. Boatto G, Nieddu M, Faedda MV, De Caprariis P. Chirality 2003; 15: 494.
11. Christians T, Holzgrabe U. Electrophoresis 2000; 21: 3609.
12. Alvarez-Lueje A, Pujol S, Squella JA, Nunez-Vergara LJ. J. Pharm. Biomed. Anal. 2003; 31: 1.
13. Mihaljica S, Radulovi D, Trbojevic J. Chromatographia 2005; 61: 25.
14. Baranda AB, Berasaluce O, Jimenez RM, Alonso RM. Chromatographia 2005; 61: 447.
15. Alvarez-Lueje A, Nunez-Vergana LJ, Pujol S, Squella JA. Electroanalysis 2002; 14: 1098.
16. Fiori J, Gotti R, Bertucci C, Cavrini V. J. Pharm. Biomed. Anal. 2006; 41: 176.
17. Baranda AB, Mueller CA, Alonso RM, Jimenez RM, Weinmann W. Ther. Drug Monit. 2005; 27: 44.
18. Wren SCA. J. Pharm.Biomed. Anal. 2005; 38: 337.
19. Churchwell MI, Twaddle NC, Meeker LR, Doerge DR. J. Chromatogr. B 2005; 825: 134.
20. Nováková L, Matysová L, Solich P. Talanta 2006; 68: 908.
21. Swartz ME. J. Liquid Chromatogr. Relat. Technol. 2005; 28: 1253.
22. Guidance for industry. Bioanalytical method validation. FDA, May 2001. Available: www.fda.gov/Cder/guidance/4252fnl.htm
23. Guidance for industry. Q2B Validation of analytical procedures: methodology. ICH, November 1996. Available: www.fda.gov/cder/guidance/1320fnl. pdf#search='ICH%20q2b'.